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Objective: To investigate the frequency of expression and stability of saccharide epitopes in 178 Haemophilus 
influenzae (39 type b and 138 non-typable) isolates from blood, cerebrospinal fluid, nasopharynx, pharynx, middle ear, 
conjunctiva, and pleural and bronchial fluid from symptomatic and asymptomatic children using five murine monoclonal 
antibodies (MAbs, MAHI 3, 4, 6, 8, 10) specific for the oligosaccharide moiety of the lipopolysaccharide (LPS) of 
H. infhenzae, which recognize defined saccharide structures. 
Methods: A whole bacteria enzyme immunoassay (EIA) and colony dot immunoblotting were used to determine the 
frequency of expression and stability of saccharide epitopes in the 178 H. influenzae isolates. 
Results: Six main groups of strains were differentiated based on the EIA binding pattern with the MAbs: group A, 
reactive with all five MAbs (MAHI 3, 4, 6, 8 and 10); group B, reactive with four MAbs (MAHI 3, 6,8 and 10); group C, 
reactive with three MAbs (MAHI 3, 6 and 8); group D, reactive with three MAbs (MAHI 3, 6 and 10); group E, reactive 
with two MAbs (MAHI 3 and 10); group F, reactive with MAb MAHI 3. Group B was the most common classification 
overall. None of the strains remained non-reactive. The frequencies of the binding patterns among the isolates obtained 
from different sources appeared to be statistically similar in most of the cases. Indications of phase variation of the LPS 
epitopes were observed with all the MAbs for strains obtained from all clinical sources as evaluated by colony dot 
immunoblotting. One of the epitopes displayed 22% phase variation, while four other epitopes were variably expressed, 
with about 50% on-off expression. 
Conclusions: This set of MAbs showed 100% reactivity among the isolates, in both EIA and colony dot immunoblotting, 
and allowed us to differentiate strains based on the LPS phenotype by whole bacteria EIA. Phase variation was indicated 
among all the isolates, independent of the source of isolation, and for all five MAbs. The LPS of isolates from different 
clinical sources often expressed some of the epitopes recognized by the MAbs, and most of the LPS phenotypes 
appeared at similar frequencies among isolates. 
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INTRODUCTION 
Haemophilu~ infuenzae causes a variety of childhood 
infections, ranging from local to invasive infections, 
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such as otitis media, sinusitis or conjunctivitis, pneu- 
monia, endocarditis, meningitis, septic arthritis and 
cellulitis. The majority of invasive H. infuenzae infec- 
tions in children are caused by organisms with the 
type b polysaccharide capsule (Hib). In total, six capsular 
polysaccharides have been identified, designated a-f 
[l]. However, most H .  influenzae infections are caused 
by non-encapsulated organisms, so-called non-typable 
H .  infuenzae (NTHi), which are commonly found 
among the normal flora colonizing the human upper 
respiratory tract [l]. There is increasing evidence that 
NTHi is an important pathogen of acute otitis media, 
sinusitis, conjunctivitis, pneumonia and other middle 
ear and lower respiratory infections [2,3]. 
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The introduction of the 13. injuenzae type b poly- 
saccharide-protein conjugate vaccine has significantly 
reduced the incidence of invasive Hib disease, but, as 
expected, has had no effect on the incidence of infec- 
tion caused by NTHi  or other capsular types [3]. 
Therefore, attention has been focused on other surface 
antigens, such as lipopolysaccharide (LPS) and con- 
served cell envelope proteins, to study their potential in 
vaccines against NTHi. 
LPS is a major bacterial cell surface component 
known to play a role in the pathogenesis of bacteremia, 
sepsis and shock caused by Gram-negative bacteria. 
LPS comprises three regions: (a) the 0-antigen, a 
polysaccharide consisting of covalently linked repetitive 
oligosaccharide building blocks; (b) the core, a non- 
repetitive oligosaccharide of six to nine sugar residues; 
and (c) lipid A, an acylated disaccharide responsible for 
LPS toxicity [4]. 
The H. irlfluenzae LPSs studied lack structures 
equivalent to the oligosaccharide repeating units which 
comprise the 0-antigen polysaccharide of Enterobac- 
teriaceae [5-71. They consist of a core oligosaccharide 
linked via a 3-deoxy-D-manno-octulosonic acid (Kdo) 
residue to a conserved lipid A region [5-71. Often, the 
core is divided into two regions: an inner core consisting 
of L-glycero-D-manno-heptose (Hep) and a phos- 
phorylated Kdo residue, and an outer oligosaccharide 
core, including mainly galactose (Gal) and glucose (Glc). 
The inner core appears to be conserved and is recog- 
nized by a monoclonal antibody (MAb), MAHI 3 
[8]. The outer core is more variable, and the fi-equent 
Table 1 H. infltrenrae clinical isolates 
switching of LPS antigenic structures in NTHi, referred 
to as phase variation [9], has been demonstrated using 
mouse MAbs with determined outer core saccharide 
epitopes [8-121. Moreover, an influence of in vitro 
growth conditions and animal passage on the epitope 
expression of H. inzuenzae LPS has been shown [ 131. 
The studies reported here aimed at identifying the 
LPS epitope expression of H. injuenzae freshly isolated 
from patients, cultured in vitro using MAbs recognizing 
a set of epitopes on H. influenzae LPS. 
This can be done with reliable and reproducible 
techniques for subtyping the bacteria, e.g. whole bac- 
teria enzyme immunoassay (EIA) for LPS with MAbs 
with known specificity, as described earlier for other 
bacterial species [14-171. We now report the dis- 
tribution of core-oligosaccharide epitopes in 178 H. 
irlfluenzae strains freshly isolated and obtained from 
different clinical sources in Uruguay, from asympto- 
matic and symptomatic children, evaluated by whole 
bacteria EIA and colony dot immunoblotting. 
MATERIALS AND METHODS 
Bacterial isolates 
Since 1988, isolates of H. irlflfluenzae from different 
clinical sources of patients and asymptomatic carriers in 
Uruguay with H. itlfluenzae-associated diseases have 
been sent from regional health centers to the Central 
Reference Laboratory of Public Health, Montevideo, 
Uruguay. Upon the arrival of samples, the strains were 
isolated and subcultivated once on chocolate agar, their 
Serotype 
Source (no. isolates) b NT Other 
Symptomatic children 
Pneumonia 
Otitis media 
Meningitis 
Cellulitis 
Sepsis 
Epiglottitis 
Conjunctivitis 
Ethmoiditis 
Asymptomatic children 
Total 
Pharyngeal swabs (37) 
Blood (17) 
Pl~eurd fluid (4) 
Bronchial brushing (1) 
hasopharyngeal swab (21) 
Middle ear fluid (25) 
Cerebrospinal fluid (13) 
Soft tissue swab (1) 
Nasopharyngeal swab (2) 
Blood (2) 
Blood (I)  
Eye swab (1) 
Ear swab (3) 
hlasopharynged swab (1) 
Pharyngeal swab (36) 
Nasopharyngeal swab (13) 
178 
3 
16 
2 
1 
2 
12 
1 
2 
1 
- 
- 
- 
- 
39 
34 
1 
2 
1 
20 
23 
1 
- 
2 
1 
3 
1 
36 
13 
138 1 
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serotypes were determined by slide agglutination with 
antisera specific for capsule types a-f, they were bio- 
typed according to a described procedure [18], and they 
were stored at -70°C in vials as suspensions in broth. 
In this study, 178 isolates (Table 1) obtained &om 
different clinical sources from both asymptomatic and 
symptomatic Uruguayan children (< 5 years), collected 
during a period of 5 years, from 1988 to 1992, were 
examined. 
Monoclonal antibodies 
The MAbs used in this study were produced and their 
epitopes characterized previously [8,11,12]. MAHI 3 
recognizes the conserved region of the Haemophilus 
LPS, defined by the Hepal+2Hepal+SHepal-+ 
5Kdo tetrasaccharide [8]. MAHI 6 and MAHI 8 
recognize an epitope in the outer-core domain of H. 
inzuenzae LPS associated with the Galal+4GalP 
&saccharide element [l l] .  MAHI 10 recognizes term- 
inal phosphorylated residues on the core of H. inzuenzae 
LPS [12], and MAHI 4 recognizes terminal P-Gal 
residues contained in the pentasaccharide GalPl-+ 
2Hepal+2Hepal+3Hepal+5Kdo of the H. in@- 
enzae LPS [12]. 
Cell-culture supernatants containing MAHI 3, 4, 
6 ,8  or 10 in RPMI 1640 and supplemented with 10% 
fetal calf serum were used. Optimization of the concen- 
tration of MAbs to be used in the tests was done by 
serial dilutions of the antibohes using the homologous 
strains as antigen. The MAb dilution that gave an A405 
21.0 after 60 min was used. 
Preparation of bacterial antigens for EIA 
H. inzuenzae strains were cultivated on chocolate 
agar plates: hemoglobin (BBL Microbiology Systems, 
Cockeysville, MD, USA) 1%; GC agar base (BBL) 4%, 
Isovitalex (BBL) 1%; incubated with 5% COz at 37°C 
overnight. Two loops full of bacteria (approximately 
10" cells) were suspended in 10 mL of phosphate- 
buffered saline (PBS, pH 7.4) and washed three times, 
by repeated cycles of centrifugation at 2000g for 20 
min. The final pellet was resuspended in 5 mL of PBS. 
The bacteria were stored at 4°C until used in whole 
bacteria EIA. 
Whole bacteria EIA 
The procedure was performed as described previously 
[15,19]. Controls included wells coated with homo- 
logous LPS or bacteria where PBS containing 0.05% 
Tween-20 (PBS-T) was substituted for MAb. All 
determinations were done in duplicate. The A405 cut- 
off value for a positive reaction in the assay was three 
times the A405 value of the non-specific background 
value of negative controls. To assess the reproducibility 
of the whole bacteria EIA method for immuno- 
typing, 60 randomly selected isolates were cultured 
and immunotyped twice, and the patterns of reactivity 
were compared. 
Colony dot immunoblotting 
The colony dot immunoblotting was done as described 
previously [19]. The results were scored as positive if 
more than 50% of the colonies were visually reactive, 
indicative of phase variation if more than 10% but less 
than 50% of the colonies were visually reactive, and 
negative when at least 90% of the colonies were non- 
reactive or only weakly reactive. 
Statistics 
All P-values are two-tailed results calculated by Fisher's 
exact test. 
RESULTS 
Assignment of LPS pattern of reactivity by whole 
bacteria EIA 
All the 178 H. intuenzae isolates were tested in EIA 
with five LPS-specific MAbs which recognize known 
epitopes. Isolates were grouped into six antigenic 
groups in accordance with the reaction pattern (A405 
20.3, after 60 min; Table 2) observed with the MAbs 
[8,11,12]. More antigenic groups could be established 
on the basis of a much lower reactivity (0.1 ~ 4 4 0 5  < 0.3) 
for some of the MAbs (not shown). Isolates were 
grouped according to the following general reaction 
patterns: group A, reactive with all the MAbs, MAHI 
3, 4, 6, 8 and 10; group B, reactive with MAHI 3, 6, 
8 and 10; group C, reactive with MAHI 3, 6 and 8; 
group D, reactive with MAHI 3, 6 and 10; group E, 
reactive with MAHI 3 and 10; and group F, reactive 
with MAHI 3. Six of the 178 strains tested only reacted 
with MAHI 3 (group F). Group B, with strains reacting 
with MAHI 3,  6, 8 and 10, was the most common 
classification overall (30%). The next most frequent 
were group D, in which strains reacted with MAHI 3, 
6 and 10 (22%), and group E, reactive with MAHI 3 
and 10 (20%) (Table 2). 
This shows that the present set of MAbs can be 
used to differentiate strains based on the LPS phenotype 
by whole bacterial EIA. 
Frequency of epitopes in isolates of H. influenzae 
determined by whole bacteria EIA in relation to 
source of isolation 
The association between the source of isolation of the 
strains and reaction pattern was examined (Figure 1). 
The most common pattern among the blood isolates 
was that of group B (MAHI 3,  6, 8 and lo), seen in 
35% of the blood isolates, followed by group E (MAHI 
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Table 2 Antigenic grouping of H. inzuenzae strains based on reactivity patterns with LPS-specific MAbs in whole cell EIA 
~~ ~ 
Reacavity pattern with MAb" 
MAHI 
~~ 
MAHI 3 6 8 MAHI 10 MAHI 4 
Stram group IgGzb IgM IgGs IgM IgG2b No. of strains (%) 
A 
B 
C 
D 
E 
F 
No. of reactive 
% 
strains 178 
100 
137 
80 
+ 
+ 
+ 
- 
98 
55 
154 
87 
27 
15 
27 (15) 
53 (30) 
18 (10) 
39 (22) 
35 (20) 
6 (3) 
~~ 
'A4052 0.3 after 60 min in whole cell EIA. Results represent the mean of at least two determinations. 
80 
75 
70 
65 
60 
!i 5 
v) 
c) a 50 
s: 
cd 
45 
40 
35 
CI 
.I 
h 
0 
25 
20 
I5 
10 
5 
0 
(MAHI 3.4,  6, 8, 10) 
(MAHI 3, 6, 8, 10) 
(MAHI 3, 6, 8) 
(MAHI 3 , 6 ,  10) 
(MAHI 3, 10) 
(MAHI 3) 
c. 
Clinical source 
Figure 1 Frequency of core epitopes in wild-type isolates of H. inzuenzae determined by binding of monoclonal antibodes 
in whole bacteria EIA. The strains were grouped according to the pattern of reactivity defined in Table 2. 
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2 6 0  
250 - 
240 - 
230 - 
220 - 
210- 
200 - 
190 - 
180 - 
170 - 
3 and 10; 25%) and group A (all the MAbs, 25%). 
Among the nasopharyngeal isolates, the most common 
patterns were group B (MAHI 3, 6, 8 and 10; 35%), 
group D (MAHI 3, 6 and 10; 24%) and group A (all 
the M b s ,  22%). The pharyngeal strains mainly showed 
patterns D (34%) and E (25%). Among the isolates from 
the ear, the most frequently observed patterns were B 
(35%), E (29%) and C (25%). 
The frequencies of the binding patterns among 
most isolates from different sources appeared to be 
statistically similar ( P >  0.05). However, pattern D was 
more common among isolates from the pharynx than 
among those from blood (D=O.O102) or from middle 
ear fluid (P=0.0055). Pattern C was more common 
among isolates from middle ear fluid than among those 
from pharynx (P=0.04). Pattern E was more frequent 
among isolates from middle ear fluid than among those 
from cerebrospinal fluid (P=0.0398). Pattern A was 
M A H 1 3  
M A H 1 6  
M A H 1 8  
M A H I l  
M A H 1 4  
MAH13 
M A H l 6  
M A H I 8  
220 
210 
190- 
180- 
170- 
160- 
150- 
0 B 140- - 
130- 
b. 120- 
110- 
.- 
2 IW- 
90 - 
80 - 
70 - 
60- 
50 - 
40- 
30 - 
20 - 
10- 
0- 
I  
MAH14 
L 
Clinical source 
(4 
more common among isolates from cerebrospinal fluid 
than among those from pharynx (P=0.021) or from 
middle ear fluid (P=0.0022). 
Colony dot immunoblotting to analyze the epitope 
expression and their frequency in relation to source 
of isolation 
The epitope expression within the 178 isolates was 
further analyzed by MAb binding with colony dot 
immunoblotting. Broader reactivity than found in 
whole bacteria EIA was observed, with a high 
percentage of indication of phase variation (Figure 2) .  
Phase variation was indicated among al l  the isolates, 
independent of the source, and for all MAbs (Figure 
2b). Thus, it was not possible to define patterns of 
reactivity. Only 22% of the isolates indrcated phase 
variation for the MAHI 3 epitope. For the other MAbs, 
a much broader reactivity was observed with colony 
160 
I50 
140 
I30 
120 
I10 
100 
90 
80 
70 
60 
50 
40 
30 
20 
10 
0 
e! - 
= ”
2 -
m 
Clinical source 
(b) 
Figure 2 Frequency of phase-variable epitopes in wild-type isolates of H. infuetazae determined by binding of h4AHI 3, 6 ,  
8, 10 and 4 in colony dot immunoblotting. The results were scored as described in the text. (a) Number of reactive strains, 
includmg both those scored as ‘positive’ and those scored as ‘phase variation’. (b) Number of strains scored as ‘phase 
variation’. 
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dot immunoblotting than with EIA (Figure 2a), with 
indications of phase variation among reactive isolates 
varying from 41% for MAHI 10 to 48% for MAHI 6 
(Figure 2b). 
These results show an epitope which displays 22% 
of phase variation and four variably expressed epitopes 
with about 50% of on-off expression. 
DISCUSSION 
The binding of monoclonal antibodies (MAbs) specific 
for the LPS from H. infltrenzae [8,11,12] to 178 H. 
itzjuenzae strains obtained from different clinical sources 
was analyzed with a whole bacteria EIA and colony dot 
immunoblotting. 
Using a panel of five H. inzuenzae LPS-specific 
MAbs, we observed 100% reactivity among the isolates 
(Table 2)  with both whole bacteria EIA and colony dot 
immunoblotting (Figure 2a). This suggests that the LPS 
epitopes recognized by these MAbs are often expressed 
in clinical isolates, subcultivated not more than twice, 
in spite of the extensive antigenic phase variation 
showed (Figure 2b). 
The 178 isolates gave six main MAb-binding 
patterns (groups A-F; Table 2). The six main groups of 
reactivity were arbitrarily defined according to the 
presence of the saccharide epitopes as recognized by the 
MAbs. We have earlier shown by immunoblot and 
inhibition experiments that: the binding of these 
antibodies to bacterial cells in EIA corresponds to their 
binding to LPS inner- or outer-core antigenic 
determinants [8,11,12]. We hive also demonstrated that 
the MAbs do not bind to .I range of other Gram- 
negative bacilli, confirming; that the binding was 
specific and the immunologiic methods used may be 
appropriate to use as screening techniques [8,11,12]. 
The same reactivity patterns appeared in most of 
the isolates obtained from the different clinical samples 
at approximately the same frequencies (Table 2 and 
Figure l), which indicates that the LPSs from most of 
the isolates are similar (Figure 1). However, although 
some patterns of reactivity were often observed among 
isolates from certain sources, whether the expression of 
the epitopes defining the pattern has any implications 
for the pathogenicity of strains is unclear &om the data. 
The LPS typing of 178 El. inzuenzae strains can be 
summarized as follows: (1) 100% of the isolates 
expressed the Hepal +2Hepal+3Hepal+5Kdo 
tetrasaccharide element recognized by MAHI 3; (2)  
80% of the strains expressed at least one of the 
Galal-+4Galp associated saccharide epitopes; (3) 87% 
of the strains expressed the phosphorylated saccharide 
epitope recognized by MAHI 10; (4) 67% of the strains 
expressed both Galal+4Galp and the epitope 
containing the phosphorylated saccharide; (5) 15% of 
the isolates expressed all the epitopes recognized by the 
five MAbs; and (6) six strains (3%) bound only to 
MAHI 3. Whether this means that the strains only have 
the MAHI 3-defined Hepal+2Hepal+3Hepal+ 
5Kdo tetrasaccharide, or they express unrecognized 
hexose branches, remains to be investigated. 
The colony dot immunoblotting showed the 
following: (1) a conserved epitope, expressed in all the 
strains, recognized by MAHI 3, indicating 22% ofphase 
variation-we have earlier demonstrated that the 
epitope is always present, but it can be masked or 
inaccessible [8];  and (2) four variably expressed epitopes 
with indications of about 50% of phase variation 
(Figure 2). The frequencies of phase variation indicated 
for each of the other MAbs were similar for all the 
isolates, independent of the source of isolation (Figure 
2b). 
Detailed knowledge about the expression and 
accessibility of core epitopes and the presence of cross- 
reactive epitopes may have important implications for 
intervention strategies in prophylaxis or treatment of 
infections caused by Gram-negative bacteria [20]. 
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